Oligonucleotides containing 5,6-dihydro-5-azacytosine at cpg sites can produce potent inhibition of dna cytosine-c5-methyltransferase without covalently binding to the enzyme

Antisense and Nucleic Acid Drug Development

Volumn 9, Issue 4, 1999, Pages 415-421

  Marquez, V E ^a   Goddard, A ^a   Alvarez, E ^a   Ford, H ^a   Christman, J K ^b   Sheikhnejad, G ^b   Brank, A ^b   Marasco, C J ^c   Suffrin, J R ^c   O'Gara, M ^d   Cheng, X ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18244408991     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BARLETTA, J.M., RAINIER, S., and FEINBERG, A.P. (1997). Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine. Cancer Res. 57, 48-50.
2. BEISLER, J.A. (1978). Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside, 5-azacytidine. J. Med. Chem. 21, 204.
3. BEISLER, J.A., ABBASI, M.M., KELLEY, I.A., and DRISCOLL, J.S. (1977). Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine. J. Med. Chem. 20, 806-812.
4. CARR, B.I., RAHBAR, S., DOROSHOW, J.H., BLAYNEY, D., GOLDBERG, D., LEONG, J., and ASMERON, Y. (1987). Fetal hemoglobin gene activation in phase II study of 5.6-dihydro-5-azacytidine for bronchogenic carcinoma. Cancer Res. 47, 4199-4201.
5. CHEN, L., MACMILLAN, A.M., CHANG, W., EZAZ-NIKPAY, K., LANE, W.S., and VERDINE, G.L. (1991). Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase. Biochemistry 30, 11018-11025.
6. CHENG, X. (1995). Structure and function of DNA methyltransferases. Annu. Rev. Biophys. Biomol. Struct. 24, 293-318.
7. CHRISTMAN, J.K., SHEIKHNEJAD, G., MARASCO, C., and SUFRIN, J.R. (1995). 5-Methyl-2′-deoxycytidine in single-stranded DNA can act in cis to signal de novo DNA methylation. Proc. Natl. Acad. Sci. USA 92, 7347-7351.
8. COVEY, J.M., D'INCALCI, M., TILCHEN, E.J., ZAHARKO, D.S., and KOHN, K.W. (1986). Difference in DNA damage produced by incorporation of 5-aza-2′-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. Cancer Res. 46, 5511-5517.
9. CREUSOT, F., ACS, G., and CHRISTMAN, J.K. (1982). Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2′-deoxycytidine. J. Biol. Chem. 257, 2041-2048.
10. FRIEDMAN, S., and ANSARI, N. (1992). Binding of the EcoRII methyltransferase to 5-fluorocytosine-containing DNA: Isolation of a bound protein. Nucleic Acids Res. 20, 3241-3248.
11. GODDARD, A.J., and MARQUEZ, V.E. (1988). Synthesis of a phosphoramidite of 2′-deoxy-5, 6-dihydro-5-azacytidine. Its potential application in the synthesis of DNA containing dihydro-5-aza- and 5-azacytosine bases. Tetrahedron Lett. 29, 1767-1770.
12. HAAF, T. (1995). The effect of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: Implications for methylation-associated cellular processes. Pharmacol. Ther. 65, 19-46.
13. JONES, P.A. (1996). DNA methylation errors and cancer. Cancer Res. 56, 2463-2467.
14. JONES, P.A., and TAYLOR, S.M. (1980). Cellular differentiation, cytidine analogs and DNA methylation. Cell 20, 85-93.
15. JUTTERMANN, R., LI, E., and JAENISCH, R. (1994). Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl. Acad. Sci. USA 91, 11797-11801.
16. KLIMASAUSKAS, S., KUMAR, S., ROBERTS, R.J., and CHENG, X. (1994). Hhal methyltransferase lips its target base out of the DNA helix. Cell 76, 357-369.
17. LIN, KT., MOMPARLER, R.L., and RFVARD, G.E. (1981). High performance liquid chromatographic analysis and chemical stability of 5-aza-2′-deoxycytidine. J. Pharm. Sci. 70, 1228-1232.
18. MARQUEZ, V.E., LIU, P.S., KELLEY, J.A., DRISCOLL, J.S., and McCORMACK, J.J. (1980). Synthesis of 1, 3-diazepin-2-one nucleosides as transition-state inhibitors of cytidine deaminase. J. Med. Chem. 23, 713-715.
19. MATSUZAKI, J., HOTODA, H., SEKINE, M., HATA, T., HIGUCHI, S., NISHIMURA, Y., and TSUBOI, M. (1986). Self-complementary tetradeoxyribonucleoside triphosphates. Convenient chemical preparation and spectroscopic studies in solution. Tetrahedron 42, 501-513.
20. O'GARA, M., KLIMASAUKAS, S., ROBERTS, R.J., and CHENG, X. (1996). Enzymatic C5-cytosine methylation of DNA: Mechanistic implications of new crystal structures for HhaI methyltransferase-DNA-AdoHcy complexes. J. Mol. Biol. 261, 634-645.
21. POSFAI, J., BHAGWAT, A.S., POSFAI, G., and ROBERTS, R.J. (1989). Predictive motifs derived from cytosine methyltransferases. Nucleic Acids Res. 17, 2421-2433.
22. RAMCHANDANI, S., MACLEOD, R.A., PINARD, M., VON HOFE, E., and SZYF, M. (1997). Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl. Acad. Sci. USA 94, 684-698.
23. REINISCH, K.M., CHEN, L., VERDINE, G., and LIPSCOMB, W.N. (1995). The crystal structure of Haell methyltransferase covalently complexed to DNA: An extrahelical cytosine and rearranged base flipping. Cell 82, 143-153.
24. ROBERTS, R.J., and CHENG, X. (1998). Base flipping. Annu. Rev. Biochem. 67, 181-198.
25. SANTI, D.V., GARRETT, C.E., and BARR, P.J. (1983). On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 33, 9-10.
26. SEKINE, M., MATSUZAKI, J., and HATA, T. (1982). A new type of protection mode for the guanine residue by using 1,2-diisobutyrylloxyethylene group. Tetrahedron Lett. 23, 5287-5290.
27. SHEIKHNEJAD, G., BRANK, A., CHRISTMAN, J.K., GODDARD, A., ALVAREZ, E., FORD, H., Jr., MARQUEZ, V.E., MARASCO, C.J., SUFRIN, J.R., O'GARA, M., and CHENG, X. (1999). Mechanism of inhibition of DNA-(cytosine C5) methyltransferases by oligonucleotides containing 5, 6-dihydro-5-azacytosine. J. Mol. Biol. 285, 2021-2034.
28. SMITH, S.S., KAPLAN, B.E., SOWERS, L.C., and NEWMAN, E.M. (1992). Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation. Proc. Natl. Acad. Sci. USA 89, 4744-4748.
29. SZYF, M. (1998). Targeting DNA methyltransferase in cancer. Cancer Metastatis Rev. 17, 219-231.
30. WAINFAN, E., DIZIK, M., STENDER, M., and CHRISTMAN, J.K. (1989). Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets. Cancer Res. 49, 4094-4097.
31. WENTFORD, D.F., and WOLFENDEN, R. (1975). On the interaction of 3, 4, 5, 6-tetrahydrouridine with human liver cytidine deaminase. Biochemistry 14, 5099-5105.
32. WOLFENDEN, R. (1972). Analog approaches to the structure of the transition-state in enzyme reactions. Ace. Chem. Res. 5, 10-15.
33. ZINGG, J.-M., and JONES. P.A. (1997). Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18, 869-882.
34. ZINGG, J.-M., and JONES. P.A. (1997). Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 18, 869-882.